Meet some of the managers, scientists, and sales people on our team!
email@example.com · (+1) 858-565-4227 ext. 111
Ph.D. in Applied Physics, Rice University
Steve has over 20 years of nanotechnology experience beginning with his graduate work at Rice University where he discovered a method of fabricating gold nanoshells, a nanoscale composite material that consists of a spherical silica core surrounded by an ultra-thin shell of gold. This discovery led to the formation of Nanospectra Biosciences where the gold nanoshells are in clinical trials as a cancer therapy. After receiving his PhD in Applied Physics, he joined Seashell Technology where he developed commercial applications of nanotechnology, raised capital, and managed the scientific research team. In 2004 he founded nanoComposix to accelerate the commercialization of products based on precisely engineered and highly characterized nanoparticles. He is a co-founder of Sienna Biopharmaceutics and La Jolla Nanomedical, and is on the scientific advisory boards of COLR Security and Optoglo. Steve has 10 issued patents and over 40 papers in the area of nanotechnology.
firstname.lastname@example.org · (+1) 858-565-4227 ext. 114
Ph.D. in Organometallic Chemistry, Australian National University
After receiving his PhD, Richard completed postdoctoral research at UC Irvine working on homogeneous olefin amination catalysis and silsesquioxane materials. He then worked with silicon nanoparticles for solar energy collection at UC Davis, and developed novel fluorescent nanoparticles for in vivo imaging at the Sidney Kimmel Cancer Center. Richard has a diverse background in both biological systems and synthetic inorganic chemistry, and he leads bionanotechnology projects in drug delivery, molecular imaging, and wound healing.
email@example.com · (+1) 858-565-4227 ext. 125
Ph.D. in Macromolecular and Cellular Structure and Chemistry, The Scripps Research Institute
Tom has 20+ years experience in nanomaterial fabrication & development, chemistry, composite research, analytical assay development, and molecular & cell biology. He joined nanoComposix in 2005 after working with Epicyte Pharmaceuticals to rapidly scale antibody manufacturing with novel expression systems and with Chromatin, Inc. to develop analytical tools for characterizing biological macromolecules. At nanoComposix, Tom has developed technology in the areas of plasmonic nanoparticles (photothermal treatment, signature management, color perception), biomolecule-targeted nanoparticles (cancer therapy & imaging), lateral flow devices (Lyme disease vector in ticks), materials science (self-healing carbon fiber composites, thermal interface materials, transparent conductive thin films), and instruments (gold nanoparticles for MALDI imaging, single cell mass spectrometer (SCMS) based on ATOFMS technology). Tom is currently focused on transferring projects from early stage R&D into regulated development and manufacturing programs. He established the nanoComposix Quality Management System (QMS) and built an ISO Class 8 manufacturing suite for the production of nanomaterials for medical devices. Examples of medical device products manufactured for clients at nanoComposix under the QMS include topical silver particles used in photothermal treatment (Sienna Biopharmaceuticals) and lateral flow test strips for mapping loiasis (Drugs & Diagnostics for Tropical Diseases).
B.S. in Human Biology & B.A. in Clinical Psychology, University of California, San Diego
Andre Alfaro earned his B.S. in Human Biology and B.A. in Clinical Psychology from University of California, San Diego, where he spent several years characterizing surface markers on cancel stem cells for potential use as targets for nanoparticle delivery systems of cancer vaccines. He then joined Astute Medical in 2008 where he began a career developing and commercializing dozens of in vitro diagnostic tests on both the lateral flow and ELISA platforms for multiple disease indications. His work on the identification of acute kidney biomarkers led to a successful de novo 510(K) submission and CE mark of the NephroCheck test. In 2018, he joined the nanoComposix team to bring his 10+ years of development, quality and regulatory training to the lateral flow group.
firstname.lastname@example.org · (+1) 858-565-4227 ext. 155
B.S. in Chemistry, Humboldt State University
David earned his B.S. in Chemistry from Humboldt State University in 2010 with a focus on materials chemistry and electrochemistry. He began working at nanoComposix in the fall of 2011 and quickly found his niche as an analytical chemist, becoming an expert on DLS, Zeta Potential and ICP-MS measurement and data analysis. As manager of the Analytical Services department, David has led the effort to establish the methodology and documentation necessary to grow and develop this department. David remains heavily involved with internal product QC and research characterization efforts.
email@example.com · (+1) 858-565-4227 ext. 151
M.S. in Earth Science from the Scripps Institution of Oceanography
John‘s background is in the effects of natural and anthropogenic aerosols on climate, and has researched atmospheric events ranging from brown clouds in the tropics to ozone loss in the Arctic. He has extensive experience with aerosol characterization instruments, mass spectrometry, chemi-luminescece instruments, and pulsed laser systems. John joined nanoComposix in 2008 and has led projects that utilize metal nanoparticles as novel obscurants to block visible, near-IR, and mid-IR regions of the spectrum. He is also developed systems to transition the manufacturing of pyrophoric metal nanoparticles used for IR decoys from research scale to production scale. He is the author of 19 peer reviewed journal articles.
Ph.D. in Physical Chemistry, Université de Pau et des Pays de l’Adour (France)
Philippe did his Ph.D. on sol-gel chemistry applied to photooxidation of organic molecules. He then explored the synthesis of various inorganic nanoparticles (silica, silver, gold) as well as the antibacterial properties of core-shell materials at the University of Tokyo before specializing in the synthesis of mesoporous silica nanoparticles applied to drug delivery at the University of California, Los Angeles (UCLA). After joining nanoComposix, Philippe’s main research focuses on synthesis and derivatization of silica nanoparticles for applications in nanomedicine.
firstname.lastname@example.org · (+1) 858-565-4227 ext. 126
Ph.D. in Chemical Engineering, University of Texas at Austin
Aaron is a chemical engineer with more than 15 years of experience in the design, fabrication and integration of colloidal nanoparticles into applications ranging from diagnostics to photovoltaics. During his graduate work at the University of Texas at Austin and postdoctoral research at the Hebrew University in Jerusalem, he developed new methods for synthesizing multi-component particles with novel optical and catalytic properties. As a professor at the University of Colorado at Boulder his research group studied the synthesis and shape control of colloidal metal and semiconductor nanocrystals, focusing on energy harvesting and sensing applications. He moved to nanoComposix in 2011 and leads projects working with government and commercial clients to develop materials with tailored optical properties for diagnostic, sensing, security, and energy applications.
email@example.com · (+1) 858-565-4227 ext. 121
B.S. in Chemistry, San Diego State University
Kimberly earned her B.S. in Chemistry from San Diego State University, where she spent several years working in a bioanalytical separations lab developing a detection method for autologous blood doping in elite athletes. In the 2011, she joined nanoComposix where she has focused primarily on internal research and development and custom nanoparticle formulation, with an emphasis on non-spherical and tunable plasmonic materials such as silver nanoplates and nanocubes. More recently, she has been leading the development of commercial scale GMP manufacturing of plasmonic nanomaterials.
firstname.lastname@example.org · (+1) 858-565-4227 ext. 127
Martin has 10 years of prior industry experience including organic small molecule synthesis, R&D of dye and pigmented ink formulation, and protocol development. Before coming to nanoComposix, Martin worked as a Chemical Technician at Hewlett-Packard. He joined nanoComposix in 2010 and as R&D and Production Manager is responsible for the development, production, quality control, and safety of product manufacturing. While at nanoComposix, he has overseen the launch of numerous standard products and has been a leader in establishing SOP’s & documentation guidelines, building a strong nanomaterial data base and staff development. He is listed as inventor in 2 submitted patents and has contributed to the generation of many of the documents in our ever growing knowledge base.
email@example.com · (+1) 858-565-4227 ext. 156
Liz graduated from Claremont McKenna College with a B.A. in Science and Management. As nanoComposix‘s Sales Manager she is responsible for all aspects of the sales cycle including order management, fulfillment and maintaining nanoComposix‘s high standards of customer service.
firstname.lastname@example.org · (+1) 858-565-4227 ext. 162
Rebecca graduated from Azusa Pacific University with a B.A. in Molecular Biology. Her previous sales experience includes bioconjugation reagents sales sold directly and distributed worldwide. As an Account manager she covers the western and mid-western region, supporting her customers in every stage of the sales process from product selection to final stages of product evaluation. Her role also extends to generating marketing content both written and electronic.
email@example.com · (+1) 858-565-4227 ext. 161
After receiving her Ph.D. Elonne completed postdoctoral research at UCSD and the San Diego VA Med Center studying PTHrP and the effects of IFN-gamma on the JAK STAT pathway in prostate and breast cancer cells. Elonne went on as a Staff Scientist at UCSD to study hypoxia and its effects on VEGF and erythropoietin in pregnant sheep over gestational age prior to transitioning to field sales. She brings over 20 years of outside sales experience supporting life science reagent and custom product sales. Prior to joining nanoComposix, Elonne worked at BioSource International (now Thermo Fisher Scientific), Genset Oligos (Degussa AG 2003), Estapor, French Subsidiary of Merck Chemicals specializing in latex particles for IVD assay development, and Lonza. At Estapor, she supported R&D customers seeking FDA approval for immunodiagnostic assays using fluorescent, magnetic and surface functionalized nanoparticles. At nanoComposix Elonne serves as the Eastern Account Manager for North America as well as the UK and Australia.